Deutsche Bank’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Deutsche Bank’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-38,276	Closed	-$101K	–	4631
2020 Q1	$101K	Sell	38,276 -5,736	-13%	-$9.4K	﹤0.01%	3248
2019 Q4	$51K	Buy	44,012 +22,660	+106%	+$36.2K	﹤0.01%	3970
2019 Q3	$36K	Buy	21,352 +10,673	+100%	+$32.5K	﹤0.01%	4099
2019 Q2	$49K	Sell	10,679 -7,442	-41%	-$41.7K	﹤0.01%	4520
2019 Q1	$116K	Buy	18,121 +9,886	+120%	+$51.8K	﹤0.01%	4245
2018 Q4	$41K	Sell	8,235 -6,077	-42%	-$42.5K	﹤0.01%	4553
2018 Q3	$122K	Buy	+14,312	New	+$159K	﹤0.01%	4431

Deutsche Bank's NTGN Position: Q2 2020 in Review

Deutsche Bank sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 38,276 shares — an estimated $101K sold.

Deutsche Bank first reported a position in NTGN in Q3 2018 and held it in 7 quarters. The position peaked at $122K in Q3 2018. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Deutsche Bank reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Deutsche Bank sold 38,276 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $101K.
Deutsche Bank first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
Deutsche Bank's Neon Therapeutics, Inc. Common Stock position peaked at $122K in Q3 2018.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Deutsche Bank's 13F filing for Q2 2020, filed 13 Aug 2020.